AstraZeneca earnings Q2 2026 beat analyst expectations as core EPS hit $2.63 versus a $2.48 consensus, with oncology revenue ...
Attendees at the American Legislative Exchange Council’s annual meeting will consider a number of model policies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results